Revving Up: 2 Underperforming Dividend Giants Ready To Outshine
Two dividend stocks are well-positioned for growth after adapting to challenges. Find out why CP and DHR offer solid returns ...
News Medical6h
Automated NGS library preparation for DNA sequencing using CyBio FeliX
The CyBio FeliX, a benchtop instrument for automated liquid handling tasks, was used to automate the HaloPlex Target ...
New Study at ASN Kidney Week Showcases the Accuracy of Smartphone-Enabled uACR Testing for Chronic Kidney Disease
Healthy.io, the global leader in transforming the smartphone camera into a medical device, announced the results of a new ...
BioPorto A/S: BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024
November 14, 2024Announcement no. 22 BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024 Revenue growth and strategic execution COPENHAGEN, Denm ...
manilatimes14h
BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024
Based on the progress and results obtained in the first nine months of 2024, BioPorto maintains its financial guidance for 2024, as most recently described in its Interim Report for the Second Quarter ...